Endothelium-derived vasoactive agents, AT1 receptors and inflammation

Keyphrases

• Angiotensin II Type 1 Receptor (AT1R) 100%
• Endothelium 100%
• Inflammation 100%
• Angiotensin II (Ang II) 50%
• Disease Progression 25%
• Reducing Activity 25%
• Etiology 25%
• Pharmacological Inhibitors 25%
• Nitric Oxide 25%
• Reactive Oxygen Species 25%
• Endothelial Cells 25%
• Endothelial Cell Function 25%
• Vascular Dysfunction 25%
• Blood Vessels 25%
• Clinical Application 25%
• Therapeutic Benefits 25%
• Hypertension Management 25%
• Direct Electrical Stimulation 25%
• Inflammatory Molecules 25%
• Relaxant 25%
• Endothelium-derived Constricting Factor 25%
• Inflammatory Mediators 25%
• Vascular Disease 25%
• Inflammation Response 25%
• Endothelin-1 (ET-1) 25%
• Blood Vessel Wall 25%
• Type I Receptor 25%
• Active Role 25%
• Receptor Subtypes 25%
• Evidence Support 25%
• Coagulation Disorders 25%
• Vessel Relaxation 25%
• Procoagulation 25%
• Disease Initiation 25%
• Vascular Pathology 25%
• Nuclear Factor 25%

Medicine and Dentistry

• Receptor 100%
• Vasoactive Agent 100%
• Angiotensin II 100%
• Vascular Disease 66%
• Endothelial Cell 66%
• Angiotensin Receptor 66%
• Cell Function 33%
• Nuclear Factor 33%
• Reactive Oxygen Species 33%
• Nitric Oxide 33%
• Receptor Subtype 33%
• Endothelin 1 33%
• Vascular Bundle 33%
• Inflammatory Mediator 33%
• Endothelium Derived Constricting Factor 33%
• Atherosclerosis 33%
• Blood Vessel Wall 33%
• Diseases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Inflammation 100%
• Vasoactive Agent 100%
• Angiotensin II 75%
• Vascular Disease 50%
• Angiotensin Receptor 50%
• Nuclear Factor 25%
• Nitric Oxide 25%
• Reactive Oxygen Metabolite 25%
• Atherosclerosis 25%
• Endothelin 1 25%
• Endothelium Derived Constricting Factor 25%
• Receptor Subtype 25%
• Diseases 25%